The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gastric Antisecretory Drug Market Research Report 2025
Synopsis
Both histamine H2-receptor antagonists and gastric proton pump inhibitors are now world-widely used as the first choice for the treatment of acid-related diseases.
The global Gastric Antisecretory Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gastric Antisecretory Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Antisecretory Drug.
Report Scope
The Gastric Antisecretory Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastric Antisecretory Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastric Antisecretory Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Cadila Pharmaceuticals
AstraZeneca
Jiangsu Aosaikang
Eisai
Pfizer
Altana Pharma
Takeda
NCPC
Luoxin
Segment by Type
H2-receptor Antagonists
Gastric Proton Pump Inhibitors
Others
Segment by Application
Dyspepsia
Peptic Ulcer
Gastroesophageal Reflux
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gastric Antisecretory Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gastric Antisecretory Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Both histamine H2-receptor antagonists and gastric proton pump inhibitors are now world-widely used as the first choice for the treatment of acid-related diseases.
The global Gastric Antisecretory Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gastric Antisecretory Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Antisecretory Drug.
Report Scope
The Gastric Antisecretory Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastric Antisecretory Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastric Antisecretory Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Cadila Pharmaceuticals
AstraZeneca
Jiangsu Aosaikang
Eisai
Pfizer
Altana Pharma
Takeda
NCPC
Luoxin
Segment by Type
H2-receptor Antagonists
Gastric Proton Pump Inhibitors
Others
Segment by Application
Dyspepsia
Peptic Ulcer
Gastroesophageal Reflux
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gastric Antisecretory Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gastric Antisecretory Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Gastric Antisecretory Drug Market Overview
1.1 Product Overview and Scope of Gastric Antisecretory Drug
1.2 Gastric Antisecretory Drug Segment by Type
1.2.1 Global Gastric Antisecretory Drug Market Value Comparison by Type (2024-2030)
1.2.2 H2-receptor Antagonists
1.2.3 Gastric Proton Pump Inhibitors
1.2.4 Others
1.3 Gastric Antisecretory Drug Segment by Application
1.3.1 Global Gastric Antisecretory Drug Market Value by Application: (2024-2030)
1.3.2 Dyspepsia
1.3.3 Peptic Ulcer
1.3.4 Gastroesophageal Reflux
1.3.5 Others
1.4 Global Gastric Antisecretory Drug Market Size Estimates and Forecasts
1.4.1 Global Gastric Antisecretory Drug Revenue 2019-2030
1.4.2 Global Gastric Antisecretory Drug Sales 2019-2030
1.4.3 Global Gastric Antisecretory Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gastric Antisecretory Drug Market Competition by Manufacturers
2.1 Global Gastric Antisecretory Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gastric Antisecretory Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gastric Antisecretory Drug Average Price by Manufacturers (2019-2024)
2.4 Global Gastric Antisecretory Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gastric Antisecretory Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastric Antisecretory Drug, Product Type & Application
2.7 Gastric Antisecretory Drug Market Competitive Situation and Trends
2.7.1 Gastric Antisecretory Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gastric Antisecretory Drug Players Market Share by Revenue
2.7.3 Global Gastric Antisecretory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gastric Antisecretory Drug Retrospective Market Scenario by Region
3.1 Global Gastric Antisecretory Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gastric Antisecretory Drug Global Gastric Antisecretory Drug Sales by Region: 2019-2030
3.2.1 Global Gastric Antisecretory Drug Sales by Region: 2019-2024
3.2.2 Global Gastric Antisecretory Drug Sales by Region: 2025-2030
3.3 Global Gastric Antisecretory Drug Global Gastric Antisecretory Drug Revenue by Region: 2019-2030
3.3.1 Global Gastric Antisecretory Drug Revenue by Region: 2019-2024
3.3.2 Global Gastric Antisecretory Drug Revenue by Region: 2025-2030
3.4 North America Gastric Antisecretory Drug Market Facts & Figures by Country
3.4.1 North America Gastric Antisecretory Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gastric Antisecretory Drug Sales by Country (2019-2030)
3.4.3 North America Gastric Antisecretory Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gastric Antisecretory Drug Market Facts & Figures by Country
3.5.1 Europe Gastric Antisecretory Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gastric Antisecretory Drug Sales by Country (2019-2030)
3.5.3 Europe Gastric Antisecretory Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastric Antisecretory Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Gastric Antisecretory Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gastric Antisecretory Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Gastric Antisecretory Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Gastric Antisecretory Drug Market Facts & Figures by Country
3.7.1 Latin America Gastric Antisecretory Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gastric Antisecretory Drug Sales by Country (2019-2030)
3.7.3 Latin America Gastric Antisecretory Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gastric Antisecretory Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastric Antisecretory Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gastric Antisecretory Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gastric Antisecretory Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gastric Antisecretory Drug Sales by Type (2019-2030)
4.1.1 Global Gastric Antisecretory Drug Sales by Type (2019-2024)
4.1.2 Global Gastric Antisecretory Drug Sales by Type (2025-2030)
4.1.3 Global Gastric Antisecretory Drug Sales Market Share by Type (2019-2030)
4.2 Global Gastric Antisecretory Drug Revenue by Type (2019-2030)
4.2.1 Global Gastric Antisecretory Drug Revenue by Type (2019-2024)
4.2.2 Global Gastric Antisecretory Drug Revenue by Type (2025-2030)
4.2.3 Global Gastric Antisecretory Drug Revenue Market Share by Type (2019-2030)
4.3 Global Gastric Antisecretory Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gastric Antisecretory Drug Sales by Application (2019-2030)
5.1.1 Global Gastric Antisecretory Drug Sales by Application (2019-2024)
5.1.2 Global Gastric Antisecretory Drug Sales by Application (2025-2030)
5.1.3 Global Gastric Antisecretory Drug Sales Market Share by Application (2019-2030)
5.2 Global Gastric Antisecretory Drug Revenue by Application (2019-2030)
5.2.1 Global Gastric Antisecretory Drug Revenue by Application (2019-2024)
5.2.2 Global Gastric Antisecretory Drug Revenue by Application (2025-2030)
5.2.3 Global Gastric Antisecretory Drug Revenue Market Share by Application (2019-2030)
5.3 Global Gastric Antisecretory Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Gastric Antisecretory Drug Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Cadila Pharmaceuticals
6.2.1 Cadila Pharmaceuticals Corporation Information
6.2.2 Cadila Pharmaceuticals Description and Business Overview
6.2.3 Cadila Pharmaceuticals Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Cadila Pharmaceuticals Gastric Antisecretory Drug Product Portfolio
6.2.5 Cadila Pharmaceuticals Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Gastric Antisecretory Drug Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Jiangsu Aosaikang
6.4.1 Jiangsu Aosaikang Corporation Information
6.4.2 Jiangsu Aosaikang Description and Business Overview
6.4.3 Jiangsu Aosaikang Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jiangsu Aosaikang Gastric Antisecretory Drug Product Portfolio
6.4.5 Jiangsu Aosaikang Recent Developments/Updates
6.5 Eisai
6.5.1 Eisai Corporation Information
6.5.2 Eisai Description and Business Overview
6.5.3 Eisai Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Eisai Gastric Antisecretory Drug Product Portfolio
6.5.5 Eisai Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Gastric Antisecretory Drug Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Altana Pharma
6.6.1 Altana Pharma Corporation Information
6.6.2 Altana Pharma Description and Business Overview
6.6.3 Altana Pharma Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Altana Pharma Gastric Antisecretory Drug Product Portfolio
6.7.5 Altana Pharma Recent Developments/Updates
6.8 Takeda
6.8.1 Takeda Corporation Information
6.8.2 Takeda Description and Business Overview
6.8.3 Takeda Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Takeda Gastric Antisecretory Drug Product Portfolio
6.8.5 Takeda Recent Developments/Updates
6.9 NCPC
6.9.1 NCPC Corporation Information
6.9.2 NCPC Description and Business Overview
6.9.3 NCPC Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 NCPC Gastric Antisecretory Drug Product Portfolio
6.9.5 NCPC Recent Developments/Updates
6.10 Luoxin
6.10.1 Luoxin Corporation Information
6.10.2 Luoxin Description and Business Overview
6.10.3 Luoxin Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Luoxin Gastric Antisecretory Drug Product Portfolio
6.10.5 Luoxin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastric Antisecretory Drug Industry Chain Analysis
7.2 Gastric Antisecretory Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastric Antisecretory Drug Production Mode & Process
7.4 Gastric Antisecretory Drug Sales and Marketing
7.4.1 Gastric Antisecretory Drug Sales Channels
7.4.2 Gastric Antisecretory Drug Distributors
7.5 Gastric Antisecretory Drug Customers
8 Gastric Antisecretory Drug Market Dynamics
8.1 Gastric Antisecretory Drug Industry Trends
8.2 Gastric Antisecretory Drug Market Drivers
8.3 Gastric Antisecretory Drug Market Challenges
8.4 Gastric Antisecretory Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
